|
James M. Cregg teaches courses on the structure and function of genes and recombinant gene expression. Dr. Cregg’s research focus led to the development and use of a yeast, Pichia pastoris, as a system for the production of recombinant proteins. His work has had a major impact on the development of pharmaceutical proteins such as a vaccine against hepatitis B; human serum albumen, a component for an artificial blood plasma; and the anti-angiogenic proteins, angiostatin and endostatin that have garnered attention for their potential anti-cancer properties. He holds 14 patents in this area. Dr. Cregg earned his Ph.D. in biology from Rice University. Previous select appointments have been with the Oregon Graduate Institute, the Salk Institute Biotechnology Industrial Associates, and BRL/Life Technologies. | 